BSP:A1GI34 (USA)
Business Description
Agilent Technologies Inc
NAICS : 334516
SIC : 3825
5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051
Description
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.42 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.57 | |||||
| Debt-to-EBITDA | 1.58 | |||||
| Interest Coverage | 17.5 | |||||
| Piotroski F-Score | 9/9 | |||||
| Altman Z-Score | 5.79 | |||||
| Beneish M-Score | -2.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.8 | |||||
| 3-Year EBITDA Growth Rate | 14.9 | |||||
| 3-Year EPS without NRI Growth Rate | 59.6 | |||||
| 3-Year FCF Growth Rate | 14.7 | |||||
| 3-Year Book Growth Rate | 7.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 10.56 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 6.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 100 | |||||
| 9-Day RSI | 99.64 | |||||
| 14-Day RSI | 97.33 | |||||
| 6-1 Month Momentum % | -12.14 | |||||
| 12-1 Month Momentum % | -27.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.01 | |||||
| Quick Ratio | 1.49 | |||||
| Cash Ratio | 0.67 | |||||
| Days Inventory | 103.4 | |||||
| Days Sales Outstanding | 64.99 | |||||
| Days Payable | 54.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.63 | |||||
| Dividend Payout Ratio | 0.2 | |||||
| 3-Year Dividend Growth Rate | 9.2 | |||||
| Forward Dividend Yield % | 0.63 | |||||
| 5-Year Yield-on-Cost % | 1.06 | |||||
| 3-Year Average Share Buyback Ratio | 1.7 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.98 | |||||
| Operating Margin % | 22.48 | |||||
| Net Margin % | 19.35 | |||||
| ROE % | 24.84 | |||||
| ROA % | 12.06 | |||||
| ROIC % | 15.53 | |||||
| ROC (Joel Greenblatt) % | 94.97 | |||||
| ROCE % | 17.25 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.99 | |||||
| Forward PE Ratio | 24.69 | |||||
| PE Ratio without NRI | 31.99 | |||||
| Shiller PE Ratio | 51.06 | |||||
| Price-to-Owner-Earnings | 37.28 | |||||
| PEG Ratio | 2.37 | |||||
| PS Ratio | 6.19 | |||||
| PB Ratio | 7.75 | |||||
| Price-to-Tangible-Book | 147.74 | |||||
| Price-to-Free-Cash-Flow | 38.27 | |||||
| Price-to-Operating-Cash-Flow | 30.81 | |||||
| EV-to-EBIT | 27.37 | |||||
| EV-to-Forward-EBIT | 23.5 | |||||
| EV-to-EBITDA | 22.44 | |||||
| EV-to-Forward-EBITDA | 19.64 | |||||
| EV-to-Revenue | 6.34 | |||||
| EV-to-Forward-Revenue | 5.74 | |||||
| EV-to-FCF | 39.13 | |||||
| Price-to-Projected-FCF | 2.4 | |||||
| Price-to-Median-PS-Value | 1.38 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.62 | |||||
| Price-to-Graham-Number | 14.51 | |||||
| Earnings Yield (Greenblatt) % | 3.65 | |||||
| Forward Rate of Return (Yacktman) % | 14.42 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 34,282.583 | ||
| EPS (TTM) (R$) | 10.971 | ||
| Beta | 0 | ||
| Volatility % | 35.57 | ||
| 14-Day RSI | 97.33 | ||
| 14-Day ATR (R$) | 2.107096 | ||
| 20-Day SMA (R$) | 313.499 | ||
| 12-1 Month Momentum % | -27.9 | ||
| 52-Week Range (R$) | 292.5 - 476.29 | ||
| Shares Outstanding (Mil) | 597.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Agilent Technologies Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||